Dr. Adrian Wade
Director, CEO and Chief Scientist
Dr. Wade is an internationally recognized analytical chemist. He has published over 50 peer-reviewed research papers. He developed the Company’s initial anti-THC-High product from first principles, along with multiple anti-inflammation and pain relief applications. Formerly on Chemistry faculty at University of British Columbia, he has also owned and operated Ursa Technologies Ltd, a British Columbia-based research and development consulting company, for over 30 years.
